Search results
Results from the WOW.Com Content Network
The hypoglossal nerve stimulator is a novel strategy for the treatment of obstructive sleep apnea. [ 1 ] [ 2 ] It has been gaining popularity over the last few decades and was approved in Europe in 2013 and the Food and Drug Administration (FDA) in April 2014. [ 3 ]
A doctor needs to demonstrate that people meet certain criteria and CPAP therapy has been ineffective. Inspire is a hypoglossal nerve stimulator (HNS) to treat obstructive sleep apnea.
A new electronic chip that zaps the tongue’s nerves could relieve millions of patients with a common disorder that stops them from breathing in their sleep.. The technology has the potential to ...
In April 2014, the U.S. Food and Drug Administration granted pre-market approval for use of an upper airway stimulation system in people who cannot use a continuous positive airway pressure device. The Inspire Upper Airway Stimulation system is a hypoglossal nerve stimulator that senses respiration and applies mild electrical stimulation during ...
The US Food and Drug Administration first approved the hypoglossal nerve stimulator in 2014, and to date the device has been implanted in 60,000 people worldwide, according to the manufacturer. A ...
Hypoglossal nerve stimulation, an option for some patients who have obstructive sleep apnea [28] Percutaneous tibial nerve stimulation (PTNS) for the treatment of incontinence. Peripheral nerve stimulation (PNS, which refers to simulation of nerves beyond the spine or brain, and may be considered to include occipital or sacral nerve stimulation)
Patients with a common sleep disorder have been fitted with an app-controlled device that zaps the nerves in the tongue to help them breathe overnight in a UK first. The technology could spell the ...
Hypoglossal nerve stimulator This page was last edited on 17 April 2013, at 11:29 (UTC). Text is available under the Creative Commons Attribution-ShareAlike 4 ...